The Business Times
business-time-50

Vickers Venture SPAC to merge with subsidiary of Sorrento Therapeutics

google-preferred-sourceAdd BT as a preferred source
Michelle Zhu

Michelle Zhu

Published Fri, Mar 18, 2022 · 09:50 PM

    Singapore

    VICKERS Venture Partners' Nasdaq-listed special purpose acquisition company (SPAC) Vickers Vantage Corp I is merging with Scilex Holding Company, a commercial biopharmaceutical company focused on developing and commercialising non-opioid therapies for patients with acute and chronic pain.

    Scilex Holding is a subsidiary of pharma giant Sorrento Therapeutics, which is also listed on the Nasdaq.

    Vickers Venture PartnersSPACNasdaqHealthcare

    TRENDING NOW

    Koh Boon Hwee says humans have accepted that robots can take over the most repetitive, manual tasks, but are nervous about AI, which can also think.

    With AI, it’s not about coding better; workers need to think better: Koh Boon Hwee

    Google CEO Sundar Pichai needs to have a broader, fundamental rethink of the sprawling company’s incentive and management structures.

    Google’s power struggles are killing its AI mojo

    This comes after a Citi note that lifted target prices for all Singapore banks, with a leading preference and “buy” call for DBS.

    DBS, OCBC and UOB shares hit all-time highs as sentiment improves

    The eligible projects include Sun Group’s developments linked to the Asia-Pacific Economic Cooperation summit in Phu Quoc in 2027.

    Targeted credit relief: Vietnam steers funding to Vingroup, Sun Group, Masterise megaprojects

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More